Benzinga's Volume Movers

Kythera Biopharmaceuticals

shares moved up 24.01% to $41.58. The volume of Kythera Biopharmaceuticals shares traded was 6431% higher than normal. Kythera reported positive ATX-101 top line phase III trial results for the reduction of submental fat. Repros Therapeutics

shares rose 24.13% to $26.39. The volume of Repros Therapeutics shares traded was 2120% higher than normal. Repros announced topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal®. Aeropostale

surged 17.19% to $10.09. The volume of Aeropostale shares traded was 970% higher than normal. Private equity firm Sycamore Partners bought a 7.96% stake in Aeropostale. EZchip Semiconductor

shares climbed 5.80% to $23.53. The volume of EZchip Semiconductor shares traded was 635% higher than normal. EZchip Semiconductor's PEG ratio is 1.57.